Mobile

A Post Marketing Surveillance Study Assessing the Long-term Efficacy and Safety of Aptivus Co-administered With Low-dose Ritonavir in Treatment Experienced Patients With HIV-1 Infection in the Daily C...

Mise à jour : Il y a 4 ans
Référence : NCT00976950

A Post Marketing Surveillance Study Assessing the Long-term Efficacy and Safety of Aptivus Co-administered With Low-dose Ritonavir in Treatment Experienced Patients With HIV-1 Infection in the Daily Clinical Practice

Femme et Homme

  • | Pays :
  • Romania
  • | Organes :
    • -
  • | Spécialités :
    • -

Extrait

The aim of this trial is to evaluate the safety and virological and immunological efficacy of Aptivus in treatment-experienced patients with advanced HIV-1 infection who had developed resistance to more than one protease inhibitor.

Critère d'inclusion

  • HIV Infections

Liens